Clinical trial
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
NCT01076361 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
- Lead sponsor
- Medtronic
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 1999
- Completion date
- September 30, 2010
- Enrollment
- 370 (actual)
- Sites
- 106
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia, heart failure